View PDF Version - RePub - Erasmus Universiteit Rotterdam

Pelletier J, Breunin~ W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC et al. (1991)
Germline mutations m the Wilms' tumor suppressor gene are associated with abnonnal urogenital development
in Denys-Drash syndrome. Cell 67:437-447.
Peltomaki P, Aaltonen LA, Sislonen P, Pylkkiinen L, M~klin JP, Jarvinen H, Green JS et al. (1993) Genetic
mapping of a locus predisposing to human colorectal cancer. Science 260:810-816.
Perilon~o G, Sulton LN, Goldwein IW, Gusnard D, Schut L, Biegel JA, Rorke LB et al. (1992) Childhood
meningIOmas: Experience in the modem imaging era, Pediatr Neurosurg 18:16-23.
Petrella R, Levine S, Wilmot PL, Ashar KD, Casamassima AC, Shapiro LR (1993) Multiple meningiomas in
a patient with constitutional ring chromosome 22. Am J Med Genet 47:184-186.
Powell SM, Zilz N, Dearer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein D, Kinzler KW
(1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237.
Pritchard-Iones K. Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard 1 et al. (1990) The
candidate Wilms' tumor gene is involved in genitourinary development. Nature 346:194-197.
Pulst SM, Rouleau GA, Marineau C, Fain P, Sieb jp (1993) Familial meningioma is not allelic to
neurofibromatosis 2, Neurol 43:2096-2098.
Ranson DT, Ritland SR, Kimmel DW, Moerlel CA, Dahl RI, Scheithauer BW, Kelly PJ, Jenkins RB (1992)
Cytogenetic and loss of heterozygosity studies in ependymomas, pilocyticastrocytomas and oligodendrogliomas.
Genes Chram Cancer 5:348-356.
Rausing A, Ybo W, Slenflo J (1970) Intracranial meningioma: A population study of ten years. Acta Neurol
Scand 46; 102-110.
Rey lA, Bello MJ, de Campos JM, Kusak ME, Moreno S (1987) Chromosomal composition of a series of 22
human low grade gliomas. Cancer Genet Cytogenet 29:223-237.
Rey JA, BelJo MJ, de Campos JM, Kusak E, Moreno S (1988) Chromosomal involvement secondary to -22
in human meningiomas. Cancer Genet Cytogenet 33:275-290.
Rey JA, Bello MJ. de Campos JM, Vaquero J, Kusak ME, Sarasa IL, Pestana A (1993) Abnormalities of
chromosome 22 in human brain tumors determined by combined cytogenetic and mol~ular genetic approaches.
Cancer Genet Cytogenet 66: 1-10.
Riccardi VM (1981) Von Recklinghausen Neurofibromatosis. New Engl J Med 305: 1617-1627.
Rodriguez GA, Park M (1993) Dimerizalion mediated through a leucine zipper activates the oncogenic potential
of the met receptor tyrosine kinase. Mol Cell Bioi 13:6711-6722.
Roelvink NCA, Kamphorst W, van Alphen HAM, Ramanath R (1987) Pregnancy-related primary brain and
spinal tumors. Arch Neural 44:209-215.
Romeo G, Ronchetlo P, Luo Y, Baone V, Seri M, Ceccherini I. Pasini B et al. (1994) Point mutations affecting
the tyrosine kina~e domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367:377~378.
Rouleau GA, Seizinger BR, Wertelecki W, Haines JL, Superneau DW, Martuza RL, GuseHa JF (1990)
Flanking Markers Bracket the Neurofibromatosis Type 2 (NF2) Gene on chromosome 22. Am J Hum Genet
46:323-328.
Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman I, Marineau C, Hoang-Xuan K et al. (1993)
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.
Nature 363:515~521.
Rubinfield B, Souza B, Albert I, Muller 0, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P (1993)
Association of the APC gene product with fi-Catenin. Science 262: 1731-1733.
Rubio MP, Correa KM, Ramesh V, MacColiin MM, Jacoby LB, von Deimling A, Gusella IF, Louis DN
(1994) Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54:45~
47.
Russell DS, Rubinstein U (1989) Pathology of tumours of the nervous system, 5th ed. Edward Arnold, pp 449-
516.
Rustgi AK, Dyson N, Bernards R (1991) Amino-terminal domains of c-myc and N-myc proteins mediate
49